Immatics N.V. (IMTX)
NASDAQ: IMTX · Real-Time Price · USD
6.39
-0.13 (-1.99%)
At close: Nov 13, 2026, 4:00 PM EST
6.51
+0.12 (1.88%)
After-hours: Nov 13, 2026, 7:53 PM EST

Immatics Financials Overview

Millions EUR. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
43.4448.27155.8454172.8334.76
Revenue Growth
-48.75%-69.03%188.60%-68.76%397.17%11.23%
Gross Profit
-140.39-135.577.76-64.6766.05-52.81
Operating Income
-250.69-182.02-38.62-101.7329.95-86.29
Net Income
-232.03-196.4515.22-94.6527.7-93.34
Earnings Per Share
-1.70-1.610.14-1.180.40-1.48
EPS Growth
------

Revenue by Segment

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Moderna, United States
35.6637.2562.795.37--
Bristol-Myers Squibb (BMS), United States
-11.0278.150.7126.113.14
Genmab, Denmark
--14.95-2.079.626.93
Revenue (Total)
43.4448.27155.8454172.8334.76

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
276.61469.34604.45425.9362.21145.12
Total Debt
13.9515.6416.215.414.569.85
Net Cash (Debt)
262.66453.7588.25410.49347.64135.26
Net Cash Growth
-36.63%-22.87%43.30%18.08%157.01%-40.09%
Net Cash Per Share
1.923.715.515.105.052.15

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-221.87-176.63-158.0318.23100.13-84.75
Capital Expenditures
-3.28-6.56-16.27-30.8-5.74-5.11
Free Cash Flow
-225.15-183.18-174.3-12.5794.39-89.85
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
--280.87%4.98%-119.76%38.22%-151.92%
Operating Margin
-577.10%-377.11%-24.78%-188.39%17.33%-248.23%
Pretax Margin
-535.27%-411.13%13.70%-179.63%24.32%-268.49%
Profit Margin
-534.13%-407.01%9.77%-175.29%16.03%-268.49%
FCF Margin
-518.29%-379.53%-111.85%-23.28%54.62%-258.47%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
--53.86-22.43-
Forward PE
-223.37223.37223.37223.37-
P/FCF Ratio
----6.58-
PS Ratio
17.7124.845.2614.943.6021.39